Success Metrics

Clinical Success Rate

100.0%

Based on 4 completed trials

Completion Rate

100%(4/4)

Active Trials

1(17%)

Results Posted

0%(0 trials)

Phase Distribution

Ph phase_4

17%

Ph not_applicable

50%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution4 total trials

Phase 4Post-market surveillance

1(25.0%)

N/ANon-phased studies

3(75.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

4 of 4 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(1)

Completed(4)

Other(1)

Detailed Status

Completed4

unknown1

Recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 4

Trials by Phase

Phase 41 (25.0%)

N/A3 (75.0%)

Trials by Status

unknown117%

completed467%

recruiting117%

Recent Activity

1 active trials

Showing 5 of 6

completed

Respiratory Outcome of Children From the FEPED Cohort

NCT03229317

recruitingnot_applicable

Evaluation of Gender-Affirming Treatments on Pulmonary Function in Transgender and Gender Diverse Patients

NCT05587751

completednot_applicable

Clinical Trials (6)

Showing 6 of 6 trials

NCT03229317

Respiratory Outcome of Children From the FEPED Cohort

Completed

NCT05587751Not Applicable

Evaluation of Gender-Affirming Treatments on Pulmonary Function in Transgender and Gender Diverse Patients

Recruiting

NCT04649866Not Applicable

Coronary Artery Disease in Patients With Friedreich's Ataxia

Completed

NCT04376177

Clinical Routine in Thoracic Outlet Syndrome

Unknown

NCT02689557Not Applicable

VEINEX : Venous Investigations During Exercise

Completed

NCT02877537Phase 4

Measurement of Respiratory Admittance for Pediatric Asthma Diagnosis

Completed

All 6 trials loaded

Drug Details

Intervention Type: OTHER
Total Trials: 6